Profound Medical Promotes Corporate Controller to Interim CFO Amid Leadership Shift
Event summary
- Profound Medical Corp. promotes Matthew Sobczyk from Corporate Controller to Interim CFO, effective August 14, 2026.
- Rashed Dewan steps down as CFO but will stay on for a short-term consulting contract to ensure a smooth transition.
- Sobczyk joined Profound in 2020 and is seen as having deep knowledge of the company’s operations and financial expertise.
The big picture
Profound Medical’s leadership shift comes as the company continues to expand its interventional MRI (iMRI) procedures, particularly with its flagship TULSA-PRO platform. The promotion of an internal candidate suggests a focus on maintaining operational stability while pursuing growth in global markets. The medical device industry is increasingly competitive, and governance shifts can signal strategic realignments or responses to market pressures.
What we're watching
- Operational Continuity
- How Matthew Sobczyk’s promotion will impact the company’s financial discipline and growth strategy execution.
- Strategic Focus
- Whether Profound Medical can maintain momentum in driving adoption of its TULSA technology under new leadership.
- Market Dynamics
- The pace at which Profound Medical expands its commercialization strategy for both TULSA-PRO and Sonalleve.
Related topics